Citi lowered the firm’s price target on Amdocs to $96 from $106 and keeps a Buy rating on the shares. The company reported fiscal Q4 results that were in-line with consensus expectations, the analyst tells investors in a research note The firm says the fiscal 2024 outlook highlights a key reason to own the stock. Despite a sharp spending slowdown and significant geopolitical uncertainty, Amdocs should deliver double-digit earnings growth, says Citi.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOX:
- Amdocs Limited (DOX) Q4 Earnings Cheat Sheet
- etisalat by e& selects Amdocs to transform in-store retail experience
- Amdocs, Bharti Airtel collaborate for digital transformation
- Amdocs says Israel operations ‘continue without material interruption’
- Amdocs enables migration of classic applications to Azure, OCI